Based in Parma, Italy, Chiesi Farmaceutici is an international Healthcare Group, with over 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative drugs in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas. Chiesi entered in the solid organ transplant area with Envarsus®, a prolonged-release tacrolimus formulation with a distinctive PK profile.
+39(0)5212791
Via Palermo 26/A
